Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project
Clicks: 279
ID: 5846
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
71.6
/100
279 views
226 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #881 of 1,693 articles by views in Infection and drug resistance
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,693 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (19 words).
Try re-searching for a better abstract.
| Reference Key |
paola2019lipidinfection
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Paola Bagella;Nicola Squillace;Elena Ricci;Roberto Gulminetti;Giuseppe Vittorio De Socio;Lucia Taramasso;Giovanni Pellicanò;Barbara Menzaghi;Benedetto Maurizio Celesia;Chiara Dentone;Giancarlo Orofino;Paolo Bonfanti;Giordano Madeddu and |
| Journal | Infection and drug resistance |
| Year | 2019 |
| DOI |
10.2147/IDR.S203813
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.